Princess Margaret Cancer Centre

What Princess Margaret Cancer Centre does

Princess Margaret Cancer Centre (PMCC) is a specialized cancer research, treatment, and education facility operated by University Health Network (UHN) at 610 University Avenue, Toronto. Established in 1958 as Princess Margaret Hospital under the Ontario Cancer Institute, it relocated to its current address in 1995 and became a UHN program following the 1998 amalgamation. According to the input data, it is the first and only Canadian facility devoted exclusively to cancer research, treatment, and education, and UHN ranks among the world's top hospital systems in Newsweek's rankings. PMCC's address and headcount profile are reported under the UHN umbrella, reflecting its status as one of approximately ten medical programs within the network.

PMCC's service portfolio spans the full cancer care continuum: diagnosis, chemotherapy, radiation, immunotherapy, surgery, follow-up care, hereditary cancer screening, and clinical trial access. Active research capability is demonstrated through the clinical validation of a blood-based active chromatin cell-free DNA platform in partnership with Aqtual, Inc., in 30 advanced leiomyosarcoma patients, with longitudinal results presented at ASCO 2026. A second major research asset is the Helix-partnered population genomics study enrolling 100,000 participants over five years to identify hereditary cancer and cardiovascular risk. Support services include the Care & Connect virtual patient-volunteer program, the Patient & Family Library and the Health Sciences Library for trainees and staff. PMCC also functions as a Phase 1 clinical trial site for external biotech sponsors, exemplified by Bantam Pharmaceutical's BTM-3566 trial.

PMCC is a publicly funded not-for-profit; services are reimbursed through the Ontario Health Insurance Plan (OHIP) rather than priced commercially. Capital campaigns and major gifts flow through the affiliated Princess Margaret Cancer Foundation, with the November 2025 Peter Gilgan Foundation donation of $50 million representing the largest single philanthropic commitment to early cancer detection in North America and underwriting a new three-pillar research program. The combination of provincial operating funding, federal/provincial research grants, philanthropy, and biotech-sponsored trial revenue defines a blended funding model distinct from a commercial SaaS or biotech business model.

Name

Princess Margaret Cancer Centre

Legal name

Princess Margaret Cancer Centre

Website

https://uhn.ca

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Princess Margaret Cancer Centre is Canada's first and only facility dedicated exclusively to cancer research, treatment, and education. Operated by University Health Network in Toronto, it provides comprehensive cancer care, hereditary screening, and clinical trials to patients across Ontario and Canada.

Ownership category

akta.pro rank

Product category

Cancer Care Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Cancer treatment services
• Oncology research programs
• Cancer diagnostics
• Hereditary cancer screening
• Clinical trials oncology

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Core offering

Princess Margaret Cancer Centre is a dedicated cancer research, treatment, and education facility that operates as the first and only institution in Canada devoted exclusively to cancer care. It delivers comprehensive oncology services including chemotherapy, radiation, immunotherapy, surgery, hereditary cancer screening, early detection programs, and clinical trial access. The facility is operated as part of University Health Network (UHN) and is affiliated with the University of Toronto.

Product overview

Princess Margaret Cancer Centre is a single, unified cancer care facility offering comprehensive cancer research, treatment, and education services. As part of University Health Network (UHN), it operates specialized programs including the Care & Connect virtual patient support program and maintains dedicated library services for patients and healthcare professionals. The centre focuses exclusively on cancer care and does not operate a modular platform-based product structure.

Differentiator

Problem solved

Functional benefit

Products and services

• Princess Margaret Cancer Centre A dedicated cancer research, treatment, and education facility providing comprehensive oncology services including chemotherapy, radiation, immunotherapy, surgery, early detection programs, hereditary cancer screening, and clinical trial access. Part of the University Health Network (UHN) system and affiliated with the University of Toronto.
• Care & Connect Program A virtual support program connecting cancer patients and their caregivers with trained volunteers who provide emotional support, information, and assistance with practical problem-solving through phone or video chat.
• Princess Margaret Health Sciences Library Library services at the Princess Margaret campus providing research and information resources to physicians, staff, and trainees in cancer care.

Quantifiable outcome

• Blood-based active chromatin cfDNA platform can evaluate immune, stromal, and tumor-associated genomic biology from a single blood sample in sarcoma patients
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core and flagship.

• Aqtual, Inc.coreStrategic or Co-development Partner · 1 June 2026Aqtual, Inc., a precision medicine company, partnered with UHN's Princess Margaret Cancer Centre to demonstrate its blood-based active chromatin cell-free DNA platform. The study involving 30 patients with advanced leiomyosarcoma showed the platform can evaluate immune, stromal, and tumor-associated genomic biology from a single blood sample, with further longitudinal analysis presented at ASCO 2026.
• Bantam PharmaceuticalcoreStrategic or Co-development Partner · 10 December 2025Bantam Pharmaceutical announced that the first patient was treated in its Phase 1 clinical trial for drug BTM-3566 at The Princess Margaret Cancer Centre in Toronto, Canada, aimed at aggressive cancers including lymphomas and solid tumors. The trial is assessing safety, tolerability, and early efficacy signals.
• HelixflagshipStrategic or Co-development Partner · 6 November 2025Princess Margaret Cancer Centre and Helix partnered to launch a large population genomics study in Canada involving 100,000 participants over five years. The study aims to identify genetic conditions related to cancer and cardiovascular risks, enabling earlier diagnosis and personalized healthcare decisions.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Moffitt Cancer Center: Moffitt is a NCI-designated comprehensive cancer centre in Florida focused exclusively on oncology research, treatment, and education — directly comparable to Princess Margaret's specialty cancer model.
• Dana-Farber Cancer Institute: Dana-Farber is a Harvard-affiliated specialty cancer centre focused exclusively on adult and pediatric oncology research and treatment — directly comparable to Princess Margaret's academic cancer specialty model.
• Johns Hopkins Sidney Kimmel Comprehensive Cancer Center: Johns Hopkins Sidney Kimmel Cancer Center is an NCI-designated comprehensive cancer centre within an academic hospital system — directly comparable in mission, translational research, and clinical trial activity to Princess Margaret.
• Roswell Park Comprehensive Cancer Center: Roswell Park is the oldest comprehensive cancer centre in the US, focused exclusively on cancer research and treatment — directly comparable to Princess Margaret's specialist cancer mission and translational research scope.
• Fred Hutchinson Cancer Center: Fred Hutch is an independent research-focused cancer and infectious disease centre in Seattle with strong clinical trial and population science programs — directly comparable to Princess Margaret on the research and clinical trial dimensions.
• Memorial Sloan Kettering Cancer Center: MSK is among the world's oldest and largest specialty cancer hospitals with deep research, clinical trial, and translational medicine programs — directly comparable in scope, brand, and academic mission to Princess Margaret.
• MD Anderson Cancer Center: University of Texas MD Anderson Cancer Center is the largest dedicated cancer hospital in the US and a global leader in oncology research, treatment, and education — directly comparable to Princess Margaret's role as Canada's premier cancer centre.

Broad incumbents

• Mayo Clinic Comprehensive Cancer Center: Mayo Clinic operates cancer care as part of a broader multi-specialty academic hospital system — comparable to Princess Margaret's role within UHN, with overlapping cancer research and treatment capabilities but a much wider clinical portfolio.

Regional players

• BC Cancer: BC Cancer is a provincial cancer care and research organization serving British Columbia with a comparable specialty cancer mission, but operating in a different Canadian province with its own funding and governance structure.

Others

• Ontario Institute for Cancer Research: OICR is an Ontario-based translational cancer research institute that frequently collaborates with Princess Margaret on research initiatives — thematically adjacent as a peer research organization rather than a direct care competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/UHNvolunteer
• Facebookfacebook.com/UHNvolunteer
• Instagraminstagram.com/uhnvolunteer
• LinkedInlinkedin.com/company/university-health-network

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Princess Margaret Cancer Centre